443 results on '"Capelle, Laurent"'
Search Results
2. Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma
3. Cognitive dissonance resolution depends on executive functions and frontal lobe integrity
4. Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety
5. Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastoma
6. Complications after frame-based stereotactic brain biopsy: a systematic review
7. Pseudo-continuous arterial spin labelling shows high diagnostic performance in the detection of postoperative residual lesion in hyper-vascularised adult brain tumours
8. Mechanisms and therapeutic implications of hypermutation in gliomas
9. Surgical resection of cavernous angioma located within eloquent brain areas: International survey of the practical management among 19 specialized centers
10. Cognitive impairment and morphological changes after radiation therapy in brain tumors: A review
11. The molecular landscape of glioma in patients with Neurofibromatosis 1
12. A threshold for mitotic activity and post‐surgical residual volume defines distinct prognostic groups for astrocytoma IDH‐mutant
13. N°101 – Diffuse gliomas: Frequency spectrum signatures of tumoral and peritumoral compartments
14. Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma—A phase II multicentric, randomised study
15. Supplementary Tables from Safety and Feasibility of Repeated and Transient Blood–Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma
16. Developmental venous anomaly in adult patients with diffuse glioma: A clinically relevant coexistence?
17. In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of IDH-Mutant Diffuse Gliomas
18. Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations
19. Atypical crossmodal emotional integration in patients with gliomas
20. PATH-16. THRESHOLDS OF MITOTIC ACTIVITY AND POST-SURGERY RESIDUAL VOLUME ARE INDEPENDENT PROGNOSTIC FACTORS IN ASTROCYTOMA IDH-MUTANT
21. Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study
22. Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study.
23. Patterns of relapse and growth kinetics of surgery- and radiation-refractory meningiomas
24. Differential MRI analysis for quantification of low grade glioma growth
25. Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma
26. Significant heterogeneity in the geographical distribution of diffuse grade II/III gliomas in France
27. Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France
28. The silent phase of diffuse low-grade gliomas. Is it when we missed the action?
29. Agraphia after awake surgery for brain tumor: new insights into the anatomo-functional network of writing
30. Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma
31. Biodegradable Carmustine Wafers (Gliadel) Alone or in Combination with Chemoradiotherapy: The French Experience
32. Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection
33. Influence of pregnancy in the behavior of diffuse gliomas: clinical cases of a French glioma study group
34. Epileptic seizures in diffuse low-grade gliomas in adults
35. Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm
36. Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas
37. Tumoral epileptogenicity: How does it happen?
38. French brain tumor data bank: Methodology and first results on 10,000 cases
39. Assessment of verbal working memory before and after surgery for low-grade glioma
40. Radical surgery after chemotherapy: a new therapeutic strategy to envision in grade II glioma
41. Extension of paralimbic low grade gliomas: toward an anatomical classification based on white matter invasion patterns
42. Illustration of the Added Value of 18F-DOPA PET to Multimodal MRI to Distinguish Low- and High-Grade Gliomas
43. Lymphome primitif du système nerveux central (LPSNC) et « lésion sentinelle »
44. Proton MR spectroscopy in predicting the increase of perfusion MR imaging for WHO grade II gliomas
45. IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification
46. Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety
47. Caractéristiques cliniques et moléculaires des patients long-survivants atteints de glioblastome
48. Abstract 5705: Mechanisms and therapeutic implications of hypermutation in gliomas
49. 5-Azacitidine in patients with IDH1/2-mutant recurrent glioma
50. Potentiel clinique de la spectroscopie MEGA-PRESS dans les gliomes diffus IDH mutés
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.